The use of calcium salts in the prevention and management of verapamil- induced hypotension

Annals of Pharmacotherapy

Volumn 34, Issue 5, 2000, Pages 622-629

  Moser, Lynette R ^a   Smythe, Maureen A ^b   Tisdale, James E ^c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c 228 Shapero Hall ^*

Author keywords

Calcium; Calcium channel blockers; Verapamil

Indexed keywords

CALCIUM CHLORIDE; CALCIUM SALT; GLUCONATE CALCIUM; VERAPAMIL;

CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG SAFETY; FLUSHING; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPOTENSION; NONHUMAN; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PRIORITY JOURNAL; REVIEW;

EID: 0034098651     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.18318     Document Type: Review

References (59)

1. Waxman HL, Myerburg RJ, Appel R, Sung J. Verapamil for control of ventricular rate of paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study. Ann Intern Med 1981;94:1-6.
2. Tommaso C, McDonough T, Parker M, Talano JV. Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil. Arch Intern Med 1983;143:877-81.
3. Kastor JA. Multifocal atrial tachycardia. N Engl J Med 1990;322:1713-7.
4. Cummins RO, ed. Essentials of ACLS. Advanced cardiac life support. Dallas, TX: American Heart Association, 1997:1-36-1-38.
5. Lewis BS, Mitha AS, Gotsman MS. Immediate haemodynamic effects of verapamil in man. Cardiology 1975;60:366-76.
6. Haft JI, Habbab MA. Treatment of atrial arrhythmias. Effectiveness of verapamil when preceded by calcium infusion. Arch Intern Med 1986; 146:1085-9.
7. Kieval J, Kirsten EB, Kessler KM, Mallon SM, Myerburg RJ. The effects of intravenous verapamil on hemodynamic status of patients with coronary artery disease receiving propranolol. Circulation 1982;65:653-9.
8. Barnett JC, Touchon RC. Short-term control of supraventricular tachycardia with verapamil infusion and calcium pretreatment. Chest 1990;97: 1106-9.
9. Miyagawa K, Dohi Y, Ogihara M, Sato K. Administration of intravenous calcium before verapamil to prevent hypotension in elderly patients with paroxysmal supraventricular tachycardia. J Cardiovasc Pharmacol 1993; 22:273-9.
10. Tisdale JE, Padhi ID, Goldberg AD, Silverman NA, Webb CR, Higgins RS, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998;135(5 Pt. 1):739-47.
11. Keung ECH, Aronson RS. Physiology of calcium current in cardiac muscle. Prog Cardiovasc Dis 1983;25:279-96.
12. Hariman RJ, Mangiardi LM, McAllister RG Jr, Surawicz B, Shabetai R, Kishida H. Reversal of the cardiovascular effects of verapamil by calcium and sodium: differences between electrophysiologic and hemodynamic responses. Circulation 1979;59:797-804.
13. Roy PR, Spurrell RAJ, Sowton E. The effect of verapamil on the cardiac conduction system. Postgrad Med J 1974;50:270-5.
14. Sugimoto T, Ishikawa T, Kaseno K, Nakase S. Electrophysiologic effects of diltiazem, a calcium antagonist, in patients with impaired sinus or AV node function. Angiology 1980;31:700-9.
15. Denlinger JK, Kaplan JA, Lecky JH, Wollman H. Cardiovascular responses to calcium administered intravenously to man during halothane anesthesia. Anesthesiology 1975;42:390-7.
16. Eriksen C, Sorenson MB, Bille-Brahe NE, Skovsted P, Lunding M. Haemodynamic effects of calcium chloride administered intravenously to patients with and without cardiac disease during neurolept anaesthesia. Acta Anaesthesiol Scand 1983;27:13-7.
17. Suzuki T, Aoki K. Hypertensive effects of calcium infusion in subjects with normotension and hypertension. J Hypertens 1988;6:1003-8.
18. Aoki K, Miyagawa K. Correlation of increased serum calcium with ele-vated blood pressure and vascular resistance during calcium infusion in normotensive man. J Hypertens 1990;8:579-83.
19. Kohlhardt M, Bauer B, Krause H, Fleckenstein A. Differentiation of the transmembrane Na and Ca channels in mammalian cardiac fibres by the use of specific inhibitors. Pflugers Arch 1972;335:309-22.
20. Bayer R, Hennekes R, Kaufmann R, Mannhold R. Inotropic and electro-physiological actions of verapamil and D600 in mammalian myocardium. I. Pattern of inotropic effects of the racemic compounds. Naunyn Schmiedebergs Arch Pharmacol 1975;290:49-68.
21. Imanishi S, McAllister RG Jr, Surawicz B. The effects of verapamil and lidocaine on the slow channel-dependent automatic depolarizations in guinea pig ventricular myocardium. J Pharmacol Exp Ther 1978;207: 294-303.
22. Foster PR, King RM, Nicoll AB, Zipes DP. Suppression of ouabain-induced ventricular rhythms with aprindine HCl. A comparison with other antiarrhythmic agents. Circulation 1976;53:315-21.
23. Tisdale JE, Patel RV, Webb CR, Borzak S, Zarowitz BJ. Proarrhythmic effects of intravenous vasopressors. Ann Pharmacother 1995;29:269-81.
24. Landmark K, Amlie JP. A study of the verapamil-induced changes in conductivity and refractoriness and monophasic action potentials of the dog heart in situ. Eur J Cardiol 1976;4:419-27.
25. Lang J, Timour-Chah Q, el Chebly M, Faucon G. Effect of gradual rise in plasma calcium concentration on the impairment of atrioventricular nodal conduction due to verapamil. J Cardiovasc Pharmacol 1986;8:6-13.
26. Stringer KA, Hicks P, Royal SH, Branconi JM. Sloan R. Verapamil preceded by calcium in supraventricular tachycardia. Drug Intell Clin Pharm 1988;22:575-6.
27. Guadagnino V, Greengart A, Hollander G, Solar M, Shani J, Lichstein E. Treatment of severe left ventricular dysfunction with calcium chloride in patients receiving verapamil. J Clin Pharmacol 1987;27:407-9.
28. Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive overdose of sustained-release verapamil: a case report and review of the literature. Am J Med Sci 1995;310:258-63.
29. Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker overdoses: toxicity and treatment. Ann Emerg Med 1993;22:196-200.
30. Hattori VT, Mandel WJ, Peter T. Calcium for myocardial depression from verapamil (letter). N Engl J Med 1982;306:238.
31. Morris DL, Goldschlager N. Calcium infusion for reversal of adverse effects of intravenous verapamil. JAMA 1983;249:3212-3.
32. Henry M, Kay MM, Viccellio P. Cardiogenic shock associated with calcium-channel and beta blockers: reversal with intravenous calcium chloride. Am J Emerg Med 1985;3:334-6.
33. Lipman J, Jardine I, Roos C, Dreosti L. Intravenous calcium chloride as an antidote to verapamil-induced hypotension. Intensive Care Med 1982; 8:55-7.
34. Moroni F, Mannaioni PF, Dolara A, Ciaccheri M. Calcium gluconate and hypertonic sodium chloride in a case of massive verapamil poisoning. Clin Toxicol 1980;17:395-400.
35. Woie L, Storstein L. Successful treatment of suicidal verapamil poisoning with calcium gluconate. Eur Heart J 1981;2:239-42.
36. Perkins CM. Serious verapamil poisoning: treatment with intravenous calcium gluconate. Br Med J 1978;21:1127.
37. Luscher TF, Noll G, Sturmer T, Huser B, Wenk M. Calcium gluconate in severe verapamil intoxication (letter). N Engl J Med 1994;330:718-20.
38. Kuo MJ, Tseng YZ, Chen TF, Fong DE. Verapamil overdose and severe hypocalcemia (letter). J Toxicol Clin Toxicol 1992;30:309-11.
39. Orr GM, Bodansky HJ, Dymond DS, Taylor M. Fatal verapamil overdose (letter). Lancet 1982;2:1218-9.
40. Crump BJ, Holt DW, Vale JA. Lack of response to intravenous calcium in severe verapamil poisoning (letter). Lancet 1982;2:939-40.
41. McMillan R. Management of acute severe verapamil intoxication. J Emerg Med 1988;6:193-6.
42. Horowitz BZ, Rhee KJ. Massive verapamil ingestion: a report of two cases and a review of the literature. Am J Emerg Med 1989;7:624-31.
43. Cohen IL, Fein IA, Nabi A. Reversal of cardiogenic shock and asystole in a septic patient with hypertrophie cardiomyopathy on verapamil. Crit Care Med 1990;18:775-6.
44. Cummins RO. ed. Cardiovascular pharmacology I. Advanced cardiac life support. Dallas, TX: American Heart Association. 1997;7-16-7-17.
45. Weiss AT, Lewis BS, Halon DA, Hasin Y, Gotsman MS. The use of calcium with verapamil in the management of supraventricular tachyarrhythmias. Int J Cardiol 1983;4:275-84.
46. Salerno DM, Anderson B, Sharkey PJ, Iber C. Intravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment. Ann Intern Med 1987;107:623-8.
47. Kuhn M, Schriger DL. Low-dose calcium pretreatment to prevent verapamil-induced hypotension. Am Heart J 1992;124:231-2.
48. Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy 1997;17:1238-45.
49. White RD, Goldsmith RS, Rodriguez R, Moffitt EA, Pluth JR. Plasma ionic calcium levels following injection of chloride, gluconate, and gluceptate salts of calcium. J Thorac Cardiovasc Surg 1976;71:609-13.
50. Cote CJ, Drop LJ, Daniels AL, Hoaglin DC. Calcium chloride versus calcium gluconate: comparison of ionization and cardiovascular effects in children and dogs. Anesthesiology 1987;66:465-70.
51. Martin TJ, Kang Y, Robertson KM, Virgi MA, Marquez JM. Ionization and hemodynamic effects of calcium chloride and calcium gluconate in the absence of hepatic function. Anesthesiology 1990;73:62-5.
52. Kuhn M. Severe bradyarrhythmias following calcium pretreatment. Am Heart J 1991;121(6 Pt 1):1812-3.
53. Chin RL, Garmel GM, Harter PM. Development of ventricular fibrillation after intravenous calcium chloride administration in a patient with supraventricular tachycardia. Am J Emerg Med 1995;25:416-9.
54. Gonzalez MD, Vassalle M. Role of oscillatory potential and pacemaker shifts in digitalis intoxication of the sinoatrial node. Circulation 1993;87: 1705-14.
55. Nola GT, Pope S, Harrison DC. Assessment of the synergistic relationship between serum calcium and digitalis. Am Heart J 1970;79:499-507.
56. Bower JO, Mengle HAK. The additive effect of calcium and digitalis: a warning, with a report of two deaths. JAMA 1936;106:1151-4.
57. Agus ZS, Wasserstein A, Goldfarb S. Disorders of calcium and magnesium homeostasis. Am J Med 1982;72:473-88.
58. Tohme JF, Bilezikian JP. Hypocalcemic emergencies. Endocrinol Metab Clin North Am 1993;22:363-75.
59. Yucha CB, Toto KH. Calcium and phosphorus derangements. Crit Care Nurs Clin North Am 1994;6:747-66.